| Price | 962.00p on 10-04-2026 at 18:50:07 |
|---|---|
| Change | 6.00p 0.63% |
| Buy | 968.00p |
| Sell | 954.00p |
| Last Trade: | Unknown 1,000.00 at 962.00p |
| Day's Volume: | 35,427 |
| Last Close: | 962.00p |
| Open: | 970.00p |
| ISIN: | GB0004559349 |
| Day's Range | 958.00p - 974.00p |
| 52wk Range: | 532.00p - 1,000.00p |
| Market Capitalisation: | £306.91m |
| VWAP: | 963.68027p |
| Shares in Issue: | 31.90m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1,000 | 962.00p | OTC Trade |
17:07:40 - 10-Apr-26 |
| Buy* | 36 | 962.00p | Suspected BUY Trade |
16:35:18 - 10-Apr-26 |
| Buy* | 260 | 961.206p | Suspected BUY Trade |
16:21:47 - 10-Apr-26 |
| Sell* | 3,267 | 956.00p | Ordinary |
16:15:35 - 10-Apr-26 |
| Buy* | 360 | 960.64p | Ordinary |
16:08:44 - 10-Apr-26 |
| Sell* | 587 | 962.00p | Automatic Execution |
16:08:44 - 10-Apr-26 |
| Sell* | 1,065 | 964.00p | Ordinary |
16:02:40 - 10-Apr-26 |
| Sell* | 515 | 964.72p | Ordinary |
16:02:20 - 10-Apr-26 |
| Sell* | 250 | 964.86p | Ordinary |
16:00:39 - 10-Apr-26 |
| Sell* | 313 | 959.018p | Negotiated Trade |
15:53:24 - 10-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Apr 2026 4:40 pm | RNS | Compliance with Market Abuse Regulation |
| 10th Apr 2026 12:06 pm | RNS | Net Asset Value(s) |
| 9th Apr 2026 11:32 am | RNS | Net Asset Value(s) |
| 8th Apr 2026 11:50 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 5:15 pm | RNS | Transaction in Own Shares |
| 7th Apr 2026 11:56 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 10:25 am | RNS-R | Portfolio company Soleno acquired by Neurocrine |
| 1st Apr 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Apr 2026 12:02 pm | RNS | Net Asset Value(s) |
| 31st Mar 2026 2:55 pm | RNS-R | IBT portfolio company Apellis acquired by Biogen |
